November 11 2024 - Autolus enters CAR-T race with FDA approval for Aucatzyl

Autolus enters CAR-T race with FDA approval for Aucatzyl
FDA lifts clinical hold on Novavax’s COVID/flu vaccine candidates, clears phase III trial
Advantage BMS as AbbVie drug fails schizophrenia trials
GSK calls it quits on trade group BIO for 2025
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*